Publications by authors named "Ashutosh D Wechalekar"

Claim this Profile
R
Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosis.
Muhammad Umaid Rauf, Steven Law, Marisa Santostefano, Philip N Hawkins, Aviva Petrie, Ashutosh D Wechalekar

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of isatuximab-pomalidomidedexamethasone in relapsed/refractory systemic AL amyloidosis.
Sargam Rachit Vohra, Sriram Ravichandran, Darren Foard, Ana Martinez-Naharro, Lucia Venneri, Ashutosh D Wechalekar

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncertain Clinical Relevance of Serial Bone Scintigraphy Findings in Treated Transthyretin Amyloid Cardiomyopathy.
Yousuf Razvi, Aldostefano Porcari, David F Hutt, Jonathan Lazari, Adam Ioannou, Ashutosh D Wechalekar

JACC Cardiovasc Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration.
Aldostefano Porcari, Yousuf Razvi, Francesco Cappelli, Christian Nitsche, Matteo Serenelli, Ashutosh D Wechalekar

JAMA Cardiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on B-cell maturation antigen-directed therapies in AL amyloidosis.
Krzysztof Jamroziak, Klaudia Zielonka, Jahanzaib Khwaja, Ashutosh D Wechalekar

Br J Haematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis.
Aldostefano Porcari, Ambra Masi, Ana Martinez-Naharro, Yousuf Razvi, Rishi Patel, Ashutosh D Wechalekar

JAMA Cardiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime.
Joshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja, Oliver Cohen, Muhammad U Rauf, Ashutosh D Wechalekar

Br J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.
Giacomo Chiaro, Claudia Stancanelli, Shiwen Koay, Ekawat Vichayanrat, Laura Sander, Ashutosh D Wechalekar

Clin Auton Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Jahanzaib Khwaja, Joshua Bomsztyk, Maria Atta, Ceri Bygrave, Adam Forbes, Ashutosh D Wechalekar

Br J Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement.
Richard Cheng, Michelle M Kittleson, Ashutosh D Wechalekar, Jose Alvarez-Cardona, Joshua D Mitchell

Heart· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for good clinical practice for DPD bone scintigraphy for cardiac amyloidosis.
Kshama Wechalekar, David Hutt, Ann Marie Quigley, Carol Whelan, Pei San Chan, Ashutosh D Wechalekar

Nucl Med Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis.
Joshua Bomsztyk, Sriram Ravichandran, Hannah V Giles, Nicola Wright, Oscar Berlanga, Ashutosh D Wechalekar

Blood· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
Yousuf Razvi, Adam Ioannou, Rishi K Patel, Liza Chacko, Nina Karia, Ashutosh D Wechalekar

Eur J Heart Fail· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Role of Scintigraphy Using Bone-Seeking Tracers for Diagnosis of Cardiac Amyloidosis: Expert Panel Narrative Review.
Riemer H J A Slart, Wengen Chen, Alwin Tubben, Hendrea S A Tingen, Daniel R Davies, Ashutosh D Wechalekar, Kshama Wechalekar

AJR Am J Roentgenol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and clonal characteristics of monoclonal immunoglobulin M-associated type I cryoglobulinaemia.
Jahanzaib Khwaja, Josephine M I Vos, Tessa E Pluimers, Nicole Japzon, Aisha Patel, Ashutosh D Wechalekar

Br J Haematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis.
Efstathios Kastritis, Arpit Misra, Laura Gurskyte, Florint Kroi, Andre Verhoek, Ashutosh D Wechalekar

Hematology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo, Ashutosh D Wechalekar

Leukemia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive cardiac FDG uptake in a patient with AL amyloidosis.
Suzan Hatipoglu, Ashutosh D Wechalekar, Kshama Wechalekar

J Nucl Cardiol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis.
Muhammad Umaid Rauf, Philip N Hawkins, Francesco Cappelli, Federico Perfetto, Mattia Zampieri, Ashutosh D Wechalekar

Eur Heart J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice.
Vaishali Sanchorawala, Ashutosh D Wechalekar, Kihyun Kim, Stefan O Schönland, Heather J Landau

Am J Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
Kenshi Suzuki, Ashutosh D Wechalekar, Kihyun Kim, Chihiro Shimazaki, Jin Seok Kim

Ann Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes in light chain deposition disease-analysis of a UK cohort.
Sriram Ravichandran, Steven Law, Shameem Mahmood, Brenden Wisniowski, Darren Foard, Ashutosh D Wechalekar

Am J Hematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.
Ana Martinez-Naharro, Rishi Patel, Tushar Kotecha, Nina Karia, Adam Ioannou, Ashutosh D Wechalekar

Eur Heart J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial.
Monique C Minnema, Angela Dispenzieri, Giampaolo Merlini, Raymond L Comenzo, Efstathios Kastritis, Ashutosh D Wechalekar

JACC CardioOncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: State-of-the-Art Review.
Ashutosh D Wechalekar, Marianna Fontana, C Cristina Quarta, Michaela Liedtke

JACC CardioOncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis